Sight Sciences (SGHT) gives legal chief 181,818 no-cost RSUs

Q: What is the vesting schedule for the 181,818 SGHT RSUs granted?

The 181,818 RSUs vest in four equal annual installments , beginning on August 10, 2027 and continuing annually through August 10, 2030 , conditioned on the Chief Legal Officer’s continued service with Sight Sciences through each vesting date.

Q: Does the RSU grant to the SGHT officer require any purchase price?

No. The RSU award shows a transaction price of $0.0000 per share , indicating it is a compensation grant rather than a market purchase, with shares delivered upon vesting instead of being bought for cash.

Q: What does each RSU granted by SGHT represent for the reporting person?

Each RSU granted to the Chief Legal Officer represents a contingent right to receive one share of Sight Sciences common stock, par value $0.001 per share , if and when the applicable vesting conditions are satisfied.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Sight Sciences, Inc. (SGHT) reported that its Chief Legal Officer, the reporting person in this Form 4, received an equity compensation award. The officer was granted 181,818 restricted stock units (RSUs) of common stock for no cash consideration, increasing the officer’s directly held common stock-related position to 181,818 shares on an as-converted basis.

The RSUs were granted under Sight Sciences’ 2021 Incentive Award PlanAugust 10, 2027 and continuing through August 10, 2030, subject to the officer’s continued service with Sight Sciences on each vesting date. Each RSU represents a contingent right to receive one share of Sight Sciences common stock.

Positive

None.

Negative

None.

Insider Trade Summary

Net Buyer: 181,818 shares

Net Buy 1 txn

Insider Rashid Kashif

Role Chief Legal Officer

Type Security Shares Price Value

Grant/Award Common Stock ^F1 181,818 $0.00 $0.00

Holdings After Transaction: Common Stock — 181,818 shares (Direct)

Footnotes (1)

F1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments commencing August 10, 2027 and continuing through August 10, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share.

Key Figures

RSUs granted: 181,818 shares Transaction price per share: $0.0000 per share Shares following transaction: 181,818 shares +3 more

6 metrics

RSUs granted 181,818 shares Restricted stock units granted to Chief Legal Officer on 2026-08-10

Transaction price per share $0.0000 per share Price for RSU grant to Chief Legal Officer

Shares following transaction 181,818 shares Total common stock position directly held by reporting person after grant

Par value per share $0.001 per share Par value of Sight Sciences common stock underlying the RSUs

Vesting period start August 10, 2027 First vesting date for RSU installments

Vesting period end August 10, 2030 Final vesting date for RSU installments

Key Terms

restricted stock units ("RSUs"), 2021 Incentive Award Plan, contingent right

3 terms

restricted stock units ("RSUs") financial

"Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2021 Incentive Award Plan financial

"made to the Reporting Person under the Issuer's 2021 Incentive Award Plan"

contingent right financial

"Each RSU represents a contingent right to receive one share"

FAQ

What insider equity award did SGHT report for its Chief Legal Officer?

Sight Sciences (SGHT) reported that its Chief Legal Officer received a grant of 181,818 RSUs of common stock as equity compensation under the company’s 2021 Incentive Award Plan, with no cash paid per share for the award.

How many SGHT shares does the reporting person hold after this Form 4 transaction?

After the reported transaction, the Chief Legal Officer is shown as directly holding 181,818 shares of Sight Sciences common stock on an as-converted RSU basis, all tied to this single RSU grant reported in the filing.

What is the vesting schedule for the 181,818 SGHT RSUs granted?

The 181,818 RSUs vest in four equal annual installments, beginning on August 10, 2027 and continuing annually through August 10, 2030, conditioned on the Chief Legal Officer’s continued service with Sight Sciences through each vesting date.

Does the RSU grant to the SGHT officer require any purchase price?

No. The RSU award shows a transaction price of $0.0000 per share, indicating it is a compensation grant rather than a market purchase, with shares delivered upon vesting instead of being bought for cash.

What does each RSU granted by SGHT represent for the reporting person?

Each RSU granted to the Chief Legal Officer represents a contingent right to receive one share of Sight Sciences common stock, par value $0.001 per share, if and when the applicable vesting conditions are satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/18/2026 - 06:08 PM Accepted by SEC EDGAR 08/18/2026 - 06:08 PM Learn about SEC filing dates

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person^*
Rashid Kashif
(Last) (First) (Middle)
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100
(Street)
MENLO PARK CALIFORNIA 94025
(City) (State) (Zip)
UNITED STATES
(Country) 2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ] 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/10/2026 A 181,818⁽¹⁾ A $0.00 181,818 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan (the "2021 Plan"). The RSUs vest in four equal annual installments commencing August 10, 2027 and continuing through August 10, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share.
/s/Kashif Rashid 08/18/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/10/2026		A		181,818⁽¹⁾	A	$0.00	181,818	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

	/s/Kashif Rashid	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)